ClinicalTrials.Veeva
Menu

Find clinical trials for Melanoma in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Renal Cell Carcinoma
Lung Cancer
Triple Negative Breast Cancer

Melanoma trials near San Antonio, TX, USA:

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

cell death protein-1 (PD-1) inhibitor, in patients with metastatic melanomas or advanced solid tumors. Our hypothesis is that restoration of...

Enrolling
Mucosal Melanoma
Melanoma
Drug: Phase 1b: APG-115+pembrolizumab

Phase 1, Phase 2

Ascentage Pharma Group
Ascentage Pharma Group

San Antonio, Texas, United States and 20 other locations

efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma...

Enrolling
Ocular Melanoma
Choroidal Melanoma
Device: Suprachoroidal Microinjector
Drug: Bel-sar

Phase 3

Aura Biosciences
Aura Biosciences

San Antonio, Texas, United States and 54 other locations

The study is being conducted in patients with advanced skin cancer (melanoma) who had previously been treated with fianlimab and cemiplimab ...

Invitation-only
Melanoma
Drug: Fianlimab+cemiplimab

Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

San Antonio, Texas, United States and 1 other location

Substudy 02B is part of a larger research study where researchers are looking for new ways to treat advanced melanoma that has not been trea...

Enrolling
Melanoma
Drug: Lenvatinib
Biological: Vibostolimab

Phase 1, Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

San Antonio, Texas, United States and 61 other locations

the recommended Phase 2 dose (RP2D). The study comprises a Part 1 (Dose Escalation) and a Part 2 (Dose Expansion) in solid organ tumors (melanoma...

Active, not recruiting
Advanced/Metastatic Solid Tumor
Drug: KZR-261

Phase 1

Kezar Life Sciences

San Antonio, Texas, United States and 11 other locations

This Phase 1/2, first-in-human, open-label, multicenter study follows a 3+3 ascending dose escalation design to determine the MTD/RP2D and to charact...

Enrolling
Solid Tumor, Adult
Biological: Pembrolizumab - anti-PD-1 antibody
Drug: LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER

Phase 1, Phase 2

Linnaeus Therapeutics

San Antonio, Texas, United States and 9 other locations

This is an open-label, multicenter, first-in-human dose-escalation and expansion Phase 1-2 study designed to determine the safety, tolerability, phar...

Enrolling
Cutaneous Melanoma
Metastatic Cancer
Drug: Cemiplimab
Drug: OR502

Phase 1, Phase 2

OncoResponse

San Antonio, Texas, United States and 3 other locations

A first-in-human, Phase I, open-label, multicenter study of WTX-124 administered as monotherapy and in combination with pembrolizumab to patients wit...

Enrolling
Advanced Solid Tumor
Metastatic Solid Tumor
Drug: WTX-124
Drug: pembrolizumab

Phase 1

Werewolf Therapeutics

San Antonio, Texas, United States and 10 other locations

TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase...

Enrolling
Cancer
Drug: cetuximab
Drug: FOLFIRI

Phase 1

Tizona Therapeutics

San Antonio, Texas, United States and 38 other locations

This is a Phase 1, FIH, Dose Escalation and Dose Expansion study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) e...

Enrolling
Malignant Melanoma
Non-Small Cell Lung Carcinoma
Drug: IK-595

Phase 1

Ikena Oncology

San Antonio, Texas, United States and 14 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems